Flamel Technologies: Loeb's Third Point Discloses a 9.2% "Passive" Stake

| About: Avadel Pharmaceuticals (AVDL)

In a 13G filing on Flamel Technologies (Nasdaq: FLML), Daniel Loeb's Third Point LLC disclosed a 9.2% stake (2.2 million shares) in the company. This is up from the 225,000 share stake the firm disclosed at the quarter ended March 31, 2007.

Loeb is a known activist investor and Flamel is already under activist pressure from Redwood Asset Management, which is calling for a sale.

Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications.

About this article:

Tagged: , Drug Delivery & Accessories, France
Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here